CRISPR Therapeutics to Present at Upcoming Investor Conferences
July 31 2019 - 7:01AM
CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company
focused on creating transformative gene-based medicines for serious
diseases, today announced that members of its senior management
team are scheduled to make the following presentations in August:
Canaccord Genuity Growth Conference
Date: Wednesday, August 7, 2019Presentation: 2:00 p.m. ET
Location: Boston, MA
BTIG Biotechnology Conference
Date: Monday, August 12, 2019 Panel Discussion: 2:00 p.m.
ET, Liquid Tumors: Lining Up the Treatment Options Location: New
York, NY
A live webcast of the Canaccord event will be
available on the "Events & Presentations" page in the Investors
section of the Company's website
at https://crisprtx.com/events. A replay of the webcast will
be archived on the Company's website for 14 days following the
presentation.
About CRISPR TherapeuticsCRISPR
Therapeutics is a leading gene editing company focused on
developing transformative gene-based medicines for serious diseases
using its proprietary CRISPR/Cas9 platform. CRISPR/Cas9 is a
revolutionary gene editing technology that allows for precise,
directed changes to genomic DNA. CRISPR Therapeutics has
established a portfolio of therapeutic programs across a broad
range of disease areas including hemoglobinopathies, oncology,
regenerative medicine and rare diseases. To accelerate and expand
its efforts, CRISPR Therapeutics has established strategic
collaborations with leading companies including Bayer AG, Vertex
Pharmaceuticals and ViaCyte, Inc. CRISPR Therapeutics AG is
headquartered in Zug, Switzerland, with its wholly-owned U.S.
subsidiary, CRISPR Therapeutics, Inc., and R&D operations based
in Cambridge, Massachusetts, and business offices in London, United
Kingdom. For more information, please visit www.crisprtx.com.
Investor Contact:Susan
Kimsusan.kim@crisprtx.com
Media Contact:Jennifer PaganelliWCG on behalf
of CRISPR347-658-8290jpaganelli@wcgworld.com
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Mar 2024 to Apr 2024
CRISPR Therapeutics (NASDAQ:CRSP)
Historical Stock Chart
From Apr 2023 to Apr 2024